医学
内科学
乌斯特基努马
克罗恩病
不利影响
胃肠病学
临床终点
维多利祖马布
临床试验
炎症性肠病
疾病
阿达木单抗
作者
Mathurin Fuméry,Antoine Defrance,Xavier Roblin,Romain Altwegg,Bénédicte Caron,Xavier Hébuterne,Carmen Stéfanescu,Antoine Meyer,Maria Nachury,David Laharie,Stéphane Nancey,Catherine Le Berre,Mélanie Serrero,Sophie Geyl,Cyrielle Giletta,Philippe Ah‐Soune,Nicolas Duveau,Mathieu Uzzan,Véred Abitbol,Amélie Biron
摘要
In a cohort of highly refractory patients with luminal CD and multiple prior drug failures including ustekinumab, risankizumab induction provided a clinical response in about 3 out of 4 patients and steroid-free clinical remission in about half of patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
向北要上岸
GingerF
YifanWang
Accept
嘻嘻哈哈
Kamaria
无极微光
殷勤的紫槐
捈荼
互助
9527
ZijingCao
dynamoo
ElioHuang
嘉心糖
愔愔
loii
morena
月亮不睡我不睡
皖公网安备34019202002308
